Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.36 Million | 473.42 Thousand | 232.86 Thousand | 205.71 Thousand | 410.85 Thousand | 191.47 Thousand |
| Cost of Revenue | 5.25 Million | 3.61 Million | 2.7 Million | 2.86 Million | 2.26 Million | 3.29 Million |
| Gross Profit | -3.88 Million | -3.14 Million | -2.47 Million | -2.65 Million | -1.85 Million | -3.1 Million |
| Operating Expenses | 1.36 Million | 12.7 Million | 8.87 Million | 7.95 Million | 5.88 Million | 9.14 Million |
| Selling, General and Administrative Expenses | 6.7 Million | 5.51 Million | 3.75 Million | 2.82 Million | 1.81 Million | 3.96 Million |
| Research and Development Expenses | 5.25 Million | 3.61 Million | 2.7 Million | 2.86 Million | 2.26 Million | 3.29 Million |
| Other Expenses | - | 2.56 Million | 2.61 Million | 2.42 Million | 2.02 Million | 587.94 Thousand |
| Cost and Expenses | 16.52 Million | 12.7 Million | 8.87 Million | 7.95 Million | 5.88 Million | 9.14 Million |
| Operating Income | -11.74 Million | -9.8 Million | -6.02 Million | -5.35 Million | -3.42 Million | -8.33 Million |
| Interest Expense | 985.69 Thousand | 1985.00 | 4302.00 | 6465.00 | 9158.00 | 7753.00 |
| Income Tax Expense | - | 2.56 Million | 2.61 Million | 2.43 Million | 2.03 Million | 595.7 Thousand |
| Earnings before Tax | -12.47 Million | -9.8 Million | -6.02 Million | -5.36 Million | -3.43 Million | -8.34 Million |
| Net Income | -12.47 Million | -9.8 Million | -6.02 Million | -5.36 Million | -3.43 Million | -8.34 Million |
| Earnings Per Share Basic | -0.41 | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 |
| Earnings Per Share Diluted | -0.41 | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 |
| Weighted Average Shares Outstanding | 30.48 Million | 1.12 Billion | 1.04 Billion | 747.07 Million | 362.96 Million | 234.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.48 Million | 1.12 Billion | 1.04 Billion | 747.07 Million | 362.96 Million | 234.27 Million |
| Gross Margin | -2.84 | -6.64 | -10.61 | -12.91 | -4.52 | -16.21 |
| EBIT Margin | -7.54 | -18.37 | -24.12 | -24.29 | -7.99 | -42.40 |
| Profit Margin | -9.12 | -20.72 | -25.87 | -26.07 | -8.35 | -43.56 |
| EBITDA | -10.3 Million | -8.69 Million | -5.61 Million | -4.99 Million | -3.28 Million | -8.11 Million |
| Earnings Before Tax Margin | -8.59 | -20.71 | -25.85 | -26.04 | -8.33 | -43.52 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 2.14 Million | 1.36 Million | 2.14 Million | 345 Thousand | 345 Thousand | 473.42 Thousand |
| Cost of Revenue | 1.52 Million | 5.25 Million | 1.52 Million | 1.1 Million | 1.1 Million | 3.61 Million |
| Gross Profit | 619.23 Thousand | -3.88 Million | 619.23 Thousand | -759.15 Thousand | -759.15 Thousand | -3.14 Million |
| Operating Expenses | 2.75 Million | 16.71 Million | 2.75 Million | 2.88 Million | 2.88 Million | 12.7 Million |
| Selling, General and Administrative Expenses | 2.58 Million | - | 2.58 Million | 2.56 Million | 2.56 Million | - |
| Research and Development Expenses | 1.52 Million | - | 1.52 Million | 1.1 Million | 1.1 Million | - |
| Other Expenses | - | 3.93 Million | - | - | - | 2.56 Million |
| Cost and Expenses | 4.27 Million | 17.87 Million | 4.27 Million | 3.98 Million | 3.98 Million | 12.7 Million |
| Operating Income | -2.26 Million | -11.53 Million | -2.26 Million | -3.61 Million | -3.61 Million | -9.8 Million |
| Interest Expense | - | 985.69 Thousand | - | - | - | 1985.00 |
| Income Tax Expense | - | 4.92 Million | - | - | - | 2.56 Million |
| Earnings before Tax | -2.39 Million | -12.47 Million | -2.39 Million | -3.84 Million | -3.84 Million | -9.8 Million |
| Net Income | -2.39 Million | -12.47 Million | -2.39 Million | -3.84 Million | -3.84 Million | -9.8 Million |
| Earnings Per Share Basic | -0.07 | - | -0.07 | -0.14 | -0.14 | - |
| Earnings Per Share Diluted | -0.07 | - | -0.07 | -0.14 | -0.14 | - |
| Weighted Average Shares Outstanding | 32.72 Million | 30.48 Million | 32.72 Million | 28.24 Million | 28.24 Million | 1.12 Billion |
| Weighted Average Shares Outstanding (Diluted) | 32.72 Million | 30.48 Million | 32.72 Million | 28.24 Million | 28.24 Million | 1.12 Billion |
| Gross Margin | 0.29 | -2.84 | 0.29 | -2.20 | -2.20 | -6.64 |
| EBIT Margin | -0.92 | - | -0.92 | -9.63 | -9.63 | - |
| Profit Margin | -1.12 | -9.12 | -1.12 | -11.13 | -11.13 | -20.72 |
| EBITDA | -1.96 Million | - | -1.96 Million | -3.32 Million | -3.32 Million | - |
| Earnings Before Tax Margin | -1.06 | -8.44 | -1.06 | -10.47 | -10.47 | -20.71 |
4492
6149
300176
TRZBF
LGO
2281